These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 19953653

  • 1. GABA(A) receptors mediate the attenuating effects of a 5-HT(3) receptor antagonist on methamphetamine-induced behavioral sensitization in mice.
    Yoo JH, Lee HK, Kim HC, Lee SY, Jang CG.
    Synapse; 2010 Apr; 64(4):274-9. PubMed ID: 19953653
    [Abstract] [Full Text] [Related]

  • 2. Dopamine neurotransmission is involved in the attenuating effects of 5-HT3 receptor antagonist MDL 72222 on acute methamphetamine-induced locomotor hyperactivity in mice.
    Yoo JH, Nam YS, Lee SY, Jang CG.
    Synapse; 2008 Jan; 62(1):8-13. PubMed ID: 17948891
    [Abstract] [Full Text] [Related]

  • 3. Involvement of 5-HT receptors in the development and expression of methamphetamine-induced behavioral sensitization: 5-HT receptor channel and binding study.
    Yoo JH, Cho JH, Yu HS, Lee KW, Lee BH, Jeong SM, Nah SY, Kim HC, Lee SY, Jang CG.
    J Neurochem; 2006 Nov; 99(3):976-88. PubMed ID: 16942594
    [Abstract] [Full Text] [Related]

  • 4. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
    Ago Y, Nakamura S, Uda M, Kajii Y, Abe M, Baba A, Matsuda T.
    Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
    [Abstract] [Full Text] [Related]

  • 5. Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice.
    Ago Y, Nakamura S, Kajita N, Uda M, Hashimoto H, Baba A, Matsuda T.
    Synapse; 2007 Sep; 61(9):757-63. PubMed ID: 17568413
    [Abstract] [Full Text] [Related]

  • 6. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H, Sato H, Ida I, Oshima A, Sakurai N, Shihara N, Horikawa Y, Mikuni M.
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [Abstract] [Full Text] [Related]

  • 7. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
    Shuto T, Kuroiwa M, Hamamura M, Yabuuchi K, Shimazoe T, Watanabe S, Nishi A, Yamamoto T.
    Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
    [Abstract] [Full Text] [Related]

  • 8. Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm.
    Bailey A, Metaxas A, Yoo JH, McGee T, Kitchen I.
    Eur J Neurosci; 2008 Aug; 28(4):759-70. PubMed ID: 18671743
    [Abstract] [Full Text] [Related]

  • 9. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
    Flores-Tochihuitl J, Vargas G, Morales-Medina JC, Rivera G, De La Cruz F, Zamudio S, Flores G.
    Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
    [Abstract] [Full Text] [Related]

  • 10. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
    Dhir A, Kulkarni SK.
    Brain Res Bull; 2007 Sep 14; 74(1-3):58-65. PubMed ID: 17683790
    [Abstract] [Full Text] [Related]

  • 11. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
    Jones CD, Bartee JA, Leite-Browning ML, Blackshear MA.
    Cell Mol Biol (Noisy-le-grand); 2007 May 15; 53(4):15-22. PubMed ID: 17531156
    [Abstract] [Full Text] [Related]

  • 12. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ, Albers LJ, Le H, Creese I.
    J Pharmacol Exp Ther; 1986 Sep 15; 238(3):846-54. PubMed ID: 3018223
    [Abstract] [Full Text] [Related]

  • 13. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May 15; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 14. The role of gamma-aminobutyric acid (GABA)-benzodiazepine neurotransmission in an animal model of methamphetamine-induced psychosis.
    Ito K.
    Hokkaido Igaku Zasshi; 1999 Mar 15; 74(2):135-44. PubMed ID: 10386162
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role of D1-like receptors in amphetamine-induced behavioral sensitization: a study using D1A receptor knockout mice.
    Karper PE, De la Rosa H, Newman ER, Krall CM, Nazarian A, McDougall SA, Crawford CA.
    Psychopharmacology (Berl); 2002 Feb 15; 159(4):407-14. PubMed ID: 11823893
    [Abstract] [Full Text] [Related]

  • 17. [Alteration of neuronal activities following repeated administration of stimulants].
    Amano T, Matsubayashi H, Sasa M.
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2002 Feb 15; 37(1):31-40. PubMed ID: 11915303
    [Abstract] [Full Text] [Related]

  • 18. Ethanol-induced behavioral sensitization is associated with dopamine receptor changes in the mouse olfactory tubercle.
    de Araujo NP, Fukushiro DF, Grassl C, Hipólide DC, Souza-Formigoni ML, Tufik S, Frussa-Filho R.
    Physiol Behav; 2009 Jan 08; 96(1):12-7. PubMed ID: 18761028
    [Abstract] [Full Text] [Related]

  • 19. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T, Seeman P, Kuroiwa M, Nishi A.
    Eur J Neurosci; 2008 May 08; 27(10):2551-7. PubMed ID: 18489579
    [Abstract] [Full Text] [Related]

  • 20. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM.
    J Pharmacol Exp Ther; 1997 Oct 08; 283(1):7-15. PubMed ID: 9336302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.